Fed. Circ. Rejects Bimeda Bovine Anti-Inflammatory Patent
The Federal Circuit on Thursday affirmed the rejection of a patent held by animal health products maker Bimeda Research & Development Ltd. related to a treatment aimed at reducing the risk...To view the full article, register now.
Already a subscriber? Click here to view full article